At one point in 2021, shares of Zomedica Pharmaceuticals (NYSEMKT: ZOM) were up more than 1,000% as it looked like the next big stock to own. The company, which focuses on pet health, has been a popular one for retail investors to bet on. But in the past three months, its valuation has fallen sharply (more than 64%), while the S&P 500 has remained up around 6% during the same period.
With Zomedica's value down, is now the time to consider loading up on this pet healthcare stock , and will doing so make you a millionaire in the long run? Let's look at why it may or may not happen, and which scenario is the more likely one.
Image source: Getty Images.
For further details see:
Could Zomedica Be a Millionaire-Maker Stock?